These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

640 related articles for article (PubMed ID: 27938379)

  • 1. STAT3 signaling drives EZH2 transcriptional activation and mediates poor prognosis in gastric cancer.
    Pan YM; Wang CG; Zhu M; Xing R; Cui JT; Li WM; Yu DD; Wang SB; Zhu W; Ye YJ; Wu Y; Wang S; Lu YY
    Mol Cancer; 2016 Dec; 15(1):79. PubMed ID: 27938379
    [TBL] [Abstract][Full Text] [Related]  

  • 2. HOX transcript antisense intergenic RNA represses E-cadherin expression by binding to EZH2 in gastric cancer.
    Chen WM; Chen WD; Jiang XM; Jia XF; Wang HM; Zhang QJ; Shu YQ; Zhao HB
    World J Gastroenterol; 2017 Sep; 23(33):6100-6110. PubMed ID: 28970725
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Regulation of CD44v6 expression in gastric carcinoma by the IL-6/STAT3 signaling pathway and its clinical significance.
    Xu YY; Guo M; Yang LQ; Zhou F; Yu C; Wang A; Pang TH; Wu HY; Zou XP; Zhang WJ; Wang L; Xu GF; Huang Q
    Oncotarget; 2017 Jul; 8(28):45848-45861. PubMed ID: 28507278
    [TBL] [Abstract][Full Text] [Related]  

  • 4. miR-27b-3p suppresses cell proliferation through targeting receptor tyrosine kinase like orphan receptor 1 in gastric cancer.
    Tao J; Zhi X; Zhang X; Fu M; Huang H; Fan Y; Guan W; Zou C
    J Exp Clin Cancer Res; 2015 Nov; 34():139. PubMed ID: 26576539
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Complement C3 overexpression activates JAK2/STAT3 pathway and correlates with gastric cancer progression.
    Yuan K; Ye J; Liu Z; Ren Y; He W; Xu J; He Y; Yuan Y
    J Exp Clin Cancer Res; 2020 Jan; 39(1):9. PubMed ID: 31928530
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Downregulated PITX1 Modulated by MiR-19a-3p Promotes Cell Malignancy and Predicts a Poor Prognosis of Gastric Cancer by Affecting Transcriptionally Activated PDCD5.
    Qiao F; Gong P; Song Y; Shen X; Su X; Li Y; Wu H; Zhao Z; Fan H
    Cell Physiol Biochem; 2018; 46(6):2215-2231. PubMed ID: 29734189
    [TBL] [Abstract][Full Text] [Related]  

  • 7. TP53 genomic status regulates sensitivity of gastric cancer cells to the histone methylation inhibitor 3-deazaneplanocin A (DZNep).
    Cheng LL; Itahana Y; Lei ZD; Chia NY; Wu Y; Yu Y; Zhang SL; Thike AA; Pandey A; Rozen S; Voorhoeve PM; Yu Q; Tan PH; Bay BH; Itahana K; Tan P
    Clin Cancer Res; 2012 Aug; 18(15):4201-12. PubMed ID: 22675170
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The polycomb group protein EZH2 induces epithelial-mesenchymal transition and pluripotent phenotype of gastric cancer cells by binding to PTEN promoter.
    Gan L; Xu M; Hua R; Tan C; Zhang J; Gong Y; Wu Z; Weng W; Sheng W; Guo W
    J Hematol Oncol; 2018 Jan; 11(1):9. PubMed ID: 29335012
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Long noncoding RNA SNHG6 regulates p21 expression via activation of the JNK pathway and regulation of EZH2 in gastric cancer cells.
    Li Y; Li D; Zhao M; Huang S; Zhang Q; Lin H; Wang W; Li K; Li Z; Huang W; Che Y; Huang C
    Life Sci; 2018 Sep; 208():295-304. PubMed ID: 30031062
    [TBL] [Abstract][Full Text] [Related]  

  • 10. STAT3-induced lncRNA HAGLROS overexpression contributes to the malignant progression of gastric cancer cells via mTOR signal-mediated inhibition of autophagy.
    Chen JF; Wu P; Xia R; Yang J; Huo XY; Gu DY; Tang CJ; De W; Yang F
    Mol Cancer; 2018 Jan; 17(1):6. PubMed ID: 29329543
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Long noncoding RNA PVT1 indicates a poor prognosis of gastric cancer and promotes cell proliferation through epigenetically regulating p15 and p16.
    Kong R; Zhang EB; Yin DD; You LH; Xu TP; Chen WM; Xia R; Wan L; Sun M; Wang ZX; De W; Zhang ZH
    Mol Cancer; 2015 Apr; 14():82. PubMed ID: 25890171
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Long Noncoding RNA LINC00673 Is Activated by SP1 and Exerts Oncogenic Properties by Interacting with LSD1 and EZH2 in Gastric Cancer.
    Huang M; Hou J; Wang Y; Xie M; Wei C; Nie F; Wang Z; Sun M
    Mol Ther; 2017 Apr; 25(4):1014-1026. PubMed ID: 28214253
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Epigenetic inactivation of paired box gene 5, a novel tumor suppressor gene, through direct upregulation of p53 is associated with prognosis in gastric cancer patients.
    Li X; Cheung KF; Ma X; Tian L; Zhao J; Go MY; Shen B; Cheng AS; Ying J; Tao Q; Sung JJ; Kung HF; Yu J
    Oncogene; 2012 Jul; 31(29):3419-30. PubMed ID: 22105368
    [TBL] [Abstract][Full Text] [Related]  

  • 14. MiR-124 induces autophagy-related cell death in cholangiocarcinoma cells through direct targeting of the EZH2-STAT3 signaling axis.
    Ma J; Weng L; Wang Z; Jia Y; Liu B; Wu S; Cao Y; Sun X; Yin X; Shang M; Mao A
    Exp Cell Res; 2018 May; 366(2):103-113. PubMed ID: 29530475
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibition of EZH2 and activation of ERRĪ³ synergistically suppresses gastric cancer by inhibiting FOXM1 signaling pathway.
    Huang B; Mu P; Yu Y; Zhu W; Jiang T; Deng R; Feng G; Wen J; Zhu X; Deng Y
    Gastric Cancer; 2021 Jan; 24(1):72-84. PubMed ID: 32529327
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Down regulation of RNA binding motif, single-stranded interacting protein 3, along with up regulation of nuclear HIF1A correlates with poor prognosis in patients with gastric cancer.
    Wu Y; Yun D; Zhao Y; Wang Y; Sun R; Yan Q; Zhang S; Lu M; Zhang Z; Lu D; Li Y
    Oncotarget; 2017 Jan; 8(1):1262-1277. PubMed ID: 27902480
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Long noncoding RNA LINC00165-induced by STAT3 exerts oncogenic properties via interaction with Polycomb Repressive Complex 2 to promote EMT in gastric cancer.
    Jin Y; Wu P; Zhao W; Wang X; Yang J; Huo X; Chen J; De W; Yang F
    Biochem Biophys Res Commun; 2018 Dec; 507(1-4):223-230. PubMed ID: 30448060
    [TBL] [Abstract][Full Text] [Related]  

  • 18. NEK9, a novel effector of IL-6/STAT3, regulates metastasis of gastric cancer by targeting ARHGEF2 phosphorylation.
    Lu G; Tian S; Sun Y; Dong J; Wang N; Zeng J; Nie Y; Wu K; Han Y; Feng B; Shang Y
    Theranostics; 2021; 11(5):2460-2474. PubMed ID: 33500736
    [No Abstract]   [Full Text] [Related]  

  • 19. EZH2-mediated epigenetic suppression of EphB3 inhibits gastric cancer proliferation and metastasis by affecting E-cadherin and vimentin expression.
    Zhao K; He J; Wang YF; Jin SD; Fan Y; Fang N; Qian J; Xu TP; Guo RH
    Gene; 2019 Feb; 686():118-124. PubMed ID: 30408551
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Increased expression of EHF via gene amplification contributes to the activation of HER family signaling and associates with poor survival in gastric cancer.
    Shi J; Qu Y; Li X; Sui F; Yao D; Yang Q; Shi B; Ji M; Hou P
    Cell Death Dis; 2016 Oct; 7(10):e2442. PubMed ID: 27787520
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 32.